quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:52:39·325d
INSIDERFiling
Akoya BioSciences Inc. logo

Chief Clinical Officer Bamford Pascal covered exercise/tax liability with 670 shares, decreasing direct ownership by 0.32% to 205,738 units (SEC Form 4)

AKYA· Akoya BioSciences Inc.
Industrials
Original source

Companies

  • AKYA
    Akoya BioSciences Inc.
    Industrials

Recent analyst ratings

  • Nov 15UpdateCraig Hallum$5.00
  • Aug 6UpdateMorgan Stanley-
  • Aug 6UpdateBTIG Research-
  • Aug 6UpdateJP Morgan-
  • Jun 21UpdateCraig Hallum$7.50
  • Dec 14UpdateGuggenheim-

Related

  • SEC279d
    SEC Form 15-12G filed by Akoya BioSciences Inc.
  • SEC284d
    SEC Form EFFECT filed by Akoya BioSciences Inc.
  • INSIDER287d
    Director Mendel Scott disposed of 28,500 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER287d
    Chief Business Officer Ramachandran Niro Ph.D acquired 62,566 shares, covered exercise/tax liability with 42,148 shares and disposed of 282,555 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER287d
    President and CEO Mckelligon Brian disposed of 947,688 shares, acquired 724,428 shares and covered exercise/tax liability with 196,866 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER287d
    Chief Legal Officer Kamocsay Jennifer disposed of 179,272 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER287d
    CFO Ek John Frederick disposed of 268,202 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER287d
    Chief Clinical Officer Bamford Pascal disposed of 205,738 shares, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022